Alkermes ALKS Medicare Part D — Accrued Sales Discounts Allowances And Reserves

Similar metrics at other companies

MDGLChargebacks, Discounts for Prompt Pay and Other Allowances — Gross To Net Adjustments Reserve

$20.83M+363%

JNJPharmaceutical — Accrued Rebates Returns And Promotions

$13B+5.7%

MDGLRebates, Co-Pay Assistance, Returns, and Other — Gross To Net Adjustments Reserve

$122.73M—

MDGLChargebacks, Discounts for Prompt Pay and Other Allowances — Provision related to sales in the current year

$37.82M+622%

ABTSales Rebates and Discounts

$682M+9.8%

INSMContract With Customer, Asset, Allowance For Current Period Sales

$33.89M+144%

Questions, answered.

What is Alkermes's medicare part d — accrued sales discounts allowances and reserves?

Alkermes (ALKS) reported medicare part d — accrued sales discounts allowances and reserves of $25.49M in Q1 2026.

How has Alkermes's medicare part d — accrued sales discounts allowances and reserves changed year-over-year?

Alkermes's medicare part d — accrued sales discounts allowances and reserves increased by 11.3% year-over-year, from $22.89M to $25.49M.

What is the long-term trend for Alkermes's medicare part d — accrued sales discounts allowances and reserves?

Over 3 years (2022 to 2025), Alkermes's medicare part d — accrued sales discounts allowances and reserves has grown at a 11.0% compound annual growth rate (CAGR), from $66.51M to $91M.

What does medicare part d — accrued sales discounts allowances and reserves mean?

This metric represents the estimated financial obligations and contra-revenue reserves specifically associated with Medicare Part D coverage for the company's pharmaceutical products. It accounts for anticipated rebates, discounts, and coverage gap liabilities that the company expects to pay to government programs or pharmacy benefit managers. These accruals are essential for accurately reporting net revenue by adjusting gross sales for expected future price concessions.